PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Aurigene Discovery Technologies Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Aurigene and Pcovery in Pact to Undertake Anti-fungal Drug Discovery - Aurigene Discovery Technologies Ltd announced a drug discovery deal with Danish start-up Pcovery - Pcovery.com
Aurigene and Pcovery in Pact to Undertake Anti-fungal Drug Discovery

 

NewswireToday - /newswire/ - Bangalore, Karnataka, India, 2010/09/09 - Aurigene Discovery Technologies Ltd announced a drug discovery deal with Danish start-up Pcovery - Pcovery.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Aurigene Discovery Technologies Ltd today announced a drug discovery deal with Danish start-up Pcovery. Under the terms of this agreement, Aurigene and Pcovery will work collaboratively to progress early hits available with Pcovery through the drug discovery cycle up to IND submission for anti-fungal indications. Aurigene will support Pcovery through its structure based discovery approaches and medicinal chemistry expertise to advance the early hits from Pcovery. Financial details of the deal have not been disclosed.

Commenting on the deal Aurigene’s CEO CSN Murthy said, “This deal demonstrates Aurigene’s pioneering position in undertaking collaborative drug discovery projects and also strengthens Aurigene’s presence in the anti-infectives space”.

Commenting on the deal Pcovery CEO Dr. Morten Jeppe Buch Pedersen says “We are truly happy to have reached a deal with Aurigene, and we believe that this agreement represents a most significant move for Pcovery. The combination of Aurigene and Pcovery, and of our shared knowledge and technology, should allow us to be able to bring innovative medicine to patients”.

About Aurigene
Established in Bangalore, India, in 2002, Aurigene (aurigene.com) is a collaborative drug discovery company with a proven track record of successful partnerships with about 10 collaborators globally. Aurigene has a pipeline of 20 discovery programs, at various stages from Hit Generation to late-stage Pre-Clinical Optimization, and has filed multiple patents in these Discovery Programs. With proprietary Structural Biology and Fragment-based Drug Design technology platforms, and experienced scientific leadership, Aurigene is a fully integrated operation with expertise in Target Validation Biology and Hit Generation to IND nomination. Focus TAs includes oncology, inflammation, metabolic disorders, and anti-infectives.Please visit the company website for further information.

About Pcovery
Based on in depth knowledge on the structure and biochemistry of selected membrane protein drug targets, Pcovery (pcovery.com) designs and develops original drugs and agrochemicals for diseases for which there is an unmet medical need. Placed in Copenhagen, Denmark, Pcovery is founded with vast experience in three-dimensional structural determination of membrane proteins, structure based drug development and medicinal chemistry. The core focus area of Pcovery is the development of safe and efficient broad-spectrum antifungal agents.

Pcovery Contact
Morten J. Buch-Pedersen, Thorvaldsensvej 57, 1871 Frederiksberg C, Denmark
P: +45 4045 2330 / E: mbp[.]pcovery.com; busdev[.]pcovery.com.

Established in Bangalore, India, in 2002, Aurigene Discovery Technologies Ltd. is a drug discovery biotech with a proven track record of successful partnerships with big and medium-sized pharma and biotech companies globally. Aurigene has 10 drug discovery collaborations and a pipeline of 16 discovery programs at various stages, from Hit Generation to late-stage Pre-Clinical Optimization, and has filed 16 patents across 6 programs. With proprietary Structural Biology and Fragment-based Drug Design technology platforms, and experienced scientific leadership, Aurigene is a fully integrated Drug Discovery company focused on Oncology, Inflammation and Metabolic Disorders.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Aurigene Discovery Technologies Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Aurigene and Pcovery in Pact to Undertake Anti-fungal Drug Discovery

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Saurabh Kapure - Aurigene.com 
+91 80 2852 1314 saurabh_k[.]aurigene.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Aurigene Discovery Technologies Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Aurigene Discovery Technologies Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Triggr & Bloom

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)